Sen. Grassley Presses HHS On Ethics Of FDA-Approved Blood Substitute Study

Grassley wants an investigation into FDA’s approval of a protocol that allowed patients to be treated with a blood substitute even though blood was available.

More from Archive

More from Pink Sheet